Healthcare Sector Insider Trading Activity

Verfolgen Sie Insider-Käufe und -Verkäufe bei Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 3,195 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) # Insidern mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Mega (1.1tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (624.3bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Mega (386.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (326.2bn) 0 Keine Aktivität — —
Pharmaceuticals & Medical Research Mega (317.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Mega (297.5bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (296.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (185.9bn) 0 Keine Aktivität — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Large (164.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (156.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (154.2bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (144.1bn) 0 Keine Aktivität — 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (140.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (137.2bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Large (134.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (132.9bn) -1–5 -$100M+ -0–15% 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (120.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (115.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (107.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (107.3bn) -1–5 -$100K–$1M -0–15% 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (105.4bn) 11–20 $100K–$1M 0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (102.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (96.7bn) 0 Keine Aktivität — 15–50%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (88.6bn) -1–5 -$100K–$1M -0–15% 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Keine Aktivität — —
Healthcare Services Large (72.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (65.5bn) 0 Keine Aktivität — 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (65.3bn) -1–5 -$100M+ -15–50% 0–15%
Healthcare Services Large (64.6bn) 1–5 $100K–$1M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Keine Aktivität — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (59.7bn) 1–5 < $100K 0–15% 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (58.7bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 1–5 $1M–$10M 0–15% —
US Cencora Inc (COR)
Healthcare Services Large (54.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (54.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.0bn) 0 Keine Aktivität — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (47.7bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (44.7bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (43.1bn) 0 Keine Aktivität — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (41.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (40.1bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (39.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.7bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (38.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) 0 Keine Aktivität — 0–15%
US Waters Corp (WAT)
Healthcare Services Large (36.2bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (33.3bn) 0 Keine Aktivität — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (33.3bn) -1–5 -$10M–$100M -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (32.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Keine Aktivität — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (31.9bn) 1–5 $100K–$1M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (31.7bn) 0 Keine Aktivität — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (29.9bn) 0 Keine Aktivität — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (29.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US Illumina Inc (ILMN)
Healthcare Services Large (28.5bn) -1–5 -$100M+ -0–15% 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (27.8bn) 6–10 $1M–$10M 0–15% 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (27.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (26.8bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.1bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (25.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (23.5bn) 0 Keine Aktivität — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (23.2bn) 1–5 $100K–$1M 0–15% 15–50%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (22.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (22.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (22.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (20.9bn) 0 -< $100K -0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (20.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.1bn) 0 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Large (20.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (19.9bn) -11–20 -$10M–$100M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (17.9bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Large (17.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.4bn) 0 Keine Aktivität — 50%+
Healthcare Services Large (17.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) -6–10 -$1M–$10M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Keine Aktivität — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 Keine Aktivität — —
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (15.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (15.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (15.2bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.0bn) 0 Keine Aktivität — 50%+